B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMD14

MOLECULAR TARGET

proteasome 26S subunit, non-ATPase 14

UniProt: O00487NCBI Gene: 102132 compounds

PSMD14 (proteasome 26S subunit, non-ATPase 14) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMD14

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.4811
2Harmaline0.691

About PSMD14 as a Drug Target

PSMD14 (proteasome 26S subunit, non-ATPase 14) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PSMD14 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMD14 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.